Elevated circulating activin A levels in malignant pleural mesothelioma patients are related to cancer cachexia and poor response to platinum-based chemotherapy
J. Paajanen (Helsinki, Finland), I. Ilonen (HELSINKI, Finland), H. Lauri (HELSINKI, Finland), T. Järvinen (HELSINKI, Finland), E. Sutinen (HELSINKI, Finland), H. Ollila (HELSINKI, Finland), E. Rouvinen (HELSINKI, Finland), K. Lemström (HELSINKI, Finland), J. Räsänen (HELSINKI, Finland), O. Ritvos (HELSINKI, Finland), K. Koli (HELSINKI, Finland), M. Myllärniemi (HELSINKI, Finland)
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Paajanen (Helsinki, Finland), I. Ilonen (HELSINKI, Finland), H. Lauri (HELSINKI, Finland), T. Järvinen (HELSINKI, Finland), E. Sutinen (HELSINKI, Finland), H. Ollila (HELSINKI, Finland), E. Rouvinen (HELSINKI, Finland), K. Lemström (HELSINKI, Finland), J. Räsänen (HELSINKI, Finland), O. Ritvos (HELSINKI, Finland), K. Koli (HELSINKI, Finland), M. Myllärniemi (HELSINKI, Finland). Elevated circulating activin A levels in malignant pleural mesothelioma patients are related to cancer cachexia and poor response to platinum-based chemotherapy. 3795
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: